Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab
ConclusionsThe development of irAEs might be associated with survival outcomes with nivolumab treatment in patients with AGC.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research